[EN] FERROPORTIN INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS DE FERROPORTINE ET PROCÉDÉS D'UTILISATION
申请人:GLOBAL BLOOD THERAPEUTICS INC
公开号:WO2020123850A1
公开(公告)日:2020-06-18
The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis.